Email Updates

You are here

Seasonal Use of PrEP in Mozambique

Status
Completed
Phase
Demo Project
Objective

The overall aim of the proposed study was to assess the feasibility and acceptability of providing short term daily oral PrEP (once daily FTC/TDF 200mg/300mg) as a potential HIV prevention tool to HIV-negative female partners of male miners in Gaza Province, Mozambique.

Additional objectives were also to identify facilitators and barriers to uptake and adherence with short term once daily PrEP for HIV prevention among female partners of miners; to assess safety of PrEP use in terms of adverse events requiring discontinuation of PrEP and social harms to evaluate effect of PrEP on sexual behaviors among participants and to assess correlation between self-reported adherence, adherence measured by pill count and drug level.

 

Prevention Option(s)
PrEP
Trial Sponsors
ICAP, WHO, The Employment Bureau of Africa (TEBA), BMGF
February 2016
May 2016
Enrollment
74
18
Years
Population
Women
Sites

Site(s) - Mozambique

Mozambique